Turning Point Benefit Group’s Revvity RVTY Stock Holding History

Turning Point Benefit Group’s Portfolio RVTY Stock Details RVTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7	Closed	-$677	–	655
2025 Q4	$677	Buy	+7	New	+$672	﹤0.01%	603

Other funds holding RVTY

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Turning Point Benefit Group's RVTY Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Revvity (RVTY) in Q1 2026, closing a stake of 7 shares — an estimated $677 sold.

Turning Point Benefit Group first reported a position in RVTY in Q4 2025 and held it in 1 quarter. The position peaked at $677 in Q4 2025. 503 funds tracked by Wall St. Rank hold RVTY as of Q1 2026.

Turning Point Benefit Group reported no remaining Revvity position as of Q1 2026 after selling out during the quarter.
Turning Point Benefit Group sold 7 Revvity shares in Q1 2026, an estimated $677.
Turning Point Benefit Group first reported a position in Revvity in Q4 2025 and held it in 1 quarter.
Turning Point Benefit Group's Revvity position peaked at $677 in Q4 2025.
503 funds tracked by Wall St. Rank held Revvity as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.